Literature DB >> 17657830

A novel approach for the construction of multiple shRNA expression vectors.

Deming Gou1, Tingting Weng, Yang Wang, Zhixin Wang, Honghao Zhang, Li Gao, Zhongming Chen, Pengcheng Wang, Lin Liu.   

Abstract

The application of RNA interference (RNAi) as a research and therapeutic tool depends on its ability to silence genes in a sequence-specific manner. Recent studies have reported that the effective knockdown of genes can be achieved by multiple short hairpin RNAs (shRNAs) in a single vector. Moreover, this approach can depress several genes simultaneously. However, current methods for the construction of multiple shRNA vectors often suffer from vector instability and are time-consuming. Here, we describe a simple, quick and low-cost approach to construct a single vector expressing four shRNA sequences driven by four different promoters. Using this vector, we were able to improve the gene silencing efficiency and make it possible to silence four different genes simultaneously, further expanding the application spectrum of RNAi, both in functional studies and therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657830     DOI: 10.1002/jgm.1080

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  27 in total

1.  Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector.

Authors:  Ami M Kabadi; David G Ousterout; Isaac B Hilton; Charles A Gersbach
Journal:  Nucleic Acids Res       Date:  2014-08-13       Impact factor: 16.971

2.  Purinergic P2X7 receptor regulates lung surfactant secretion in a paracrine manner.

Authors:  Amarjit Mishra; Narendranath Reddy Chintagari; Yujie Guo; Tingting Weng; Lijing Su; Lin Liu
Journal:  J Cell Sci       Date:  2011-01-25       Impact factor: 5.285

3.  Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection.

Authors:  Mandy Glass; Roger D Everett
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

4.  A direct comparison of strategies for combinatorial RNA interference.

Authors:  Luke S Lambeth; Nick J Van Hateren; Stuart A Wilson; Venugopal Nair
Journal:  BMC Mol Biol       Date:  2010-10-11       Impact factor: 2.946

5.  Simultaneous knockdown of the expression of two genes using multiple shRNAs and subsequent knock-in of their expression.

Authors:  Xue-Ming Xu; Min-Hyuk Yoo; Bradley A Carlson; Vadim N Gladyshev; Dolph L Hatfield
Journal:  Nat Protoc       Date:  2009-08-27       Impact factor: 13.491

6.  Construction of multiple shRNAs expression vector that inhibits FUT1 gene expression and production of the transgenic SCNT embryos in vitro.

Authors:  Jian-wen Chen; Yu Zhang; Yuan-liang Zhang; Chao Wei; Xing Liu; Na-ru Zhou; Qing Jia; Yun-sheng Li; Xiao-rong Zhang; Yun-hai Zhang
Journal:  Mol Biol Rep       Date:  2012-12-01       Impact factor: 2.316

7.  Annexin A2 interactions with Rab14 in alveolar type II cells.

Authors:  Deming Gou; Amarjit Mishra; Tingting Weng; Lijing Su; Narendranath Reddy Chintagari; Zhixin Wang; Honghao Zhang; Li Gao; Pengcheng Wang; Heidi M Stricker; Lin Liu
Journal:  J Biol Chem       Date:  2008-03-10       Impact factor: 5.157

8.  Local knockdown of ERK2 in the adult mouse brain via adeno-associated virus-mediated RNA interference.

Authors:  Barbara Di Benedetto; Barbara Di Benedetto; Benedikt Wefers; Wolfgang Wurst; Ralf Kühn
Journal:  Mol Biotechnol       Date:  2008-12-04       Impact factor: 2.695

9.  Native microRNA loop sequences can improve short hairpin RNA processing for virus gene silencing in animal cells.

Authors:  Tracey M Hinton; Terry G Wise; Pauline A Cottee; Timothy J Doran
Journal:  J RNAi Gene Silencing       Date:  2008-05-27

10.  Vacuolar ATPase regulates surfactant secretion in rat alveolar type II cells by modulating lamellar body calcium.

Authors:  Narendranath Reddy Chintagari; Amarjit Mishra; Lijing Su; Yang Wang; Sahlu Ayalew; Steven D Hartson; Lin Liu
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.